| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-adrenergic vasoconstriction in contracting forearm muscle of ageing men
1 Department of Health and Exercise Science, Colorado State University, Fort Collins, CO 80523-1582, USA
2 Department of Anaesthesiology and General Clinical Research Center, Mayo Clinic and Foundation, Rochester, MN 55905, USA
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
-adrenergic vasoconstriction (functional sympatholysis) is impaired with age in healthy humans. We measured forearm blood flow (FBF; Doppler ultrasound) and calculated the forearm vascular conductance (FVC) responses to -adrenergic receptor stimulation during rhythmic handgrip exercise (15% maximum voluntary contraction) and during a control non-exercise vasodilator condition (intra-arterial adenosine infusion) in seven young (25 ± 2 years) and eight healthy older men (65 ± 2 year). FVC responses to intra-arterial tyramine (evokes endogenous noradrenaline release), phenylephrine (1-agonist) and clonidine (2-agonist) were assessed. In young men, the vasoconstrictor responses to tyramine (–25 ± 1 versus
–56 ± 6%), phenylephrine (–11 ± 4 versus
–39 ± 4%) and clonidine (–12 ± 4 versus
–38 ± 5%; all P < 0.005) were blunted during exercise compared with adenosine. In contrast, exercise did not significantly blunt the response to tyramine (–30 ± 2 versus
–36 ± 7%; P
= 0.4) or phenylephrine (–16 ± 2 versus
–19 ± 3%; P
= 0.3) in older men, but did attenuate the response to clonidine (–22 ± 3 versus
–37 ± 6%; P < 0.05). The magnitude of functional sympatholysis, calculated as the difference in the vasoconstrictor responses during adenosine infusion and exercise, was significantly lower in older compared with young men in the presence of tyramine (–6 ± 7 versus
–31 ± 6%), phenylephrine (–3 ± 3 versus
–28 ± 4%) and clonidine (–15 ± 4 versus
–26 ± 3%; all P < 0.05). We conclude that ageing is associated with impaired functional sympatholysis in the vascular beds of contracting forearm muscle in healthy men. These findings might help explain the greater skeletal muscle vasoconstrictor tone and reduced blood flow during large muscle dynamic exercise in older adults.
(Received 29 March 2005;
accepted after revision 6 June 2005;
first published online 9 June 2005)
Corresponding author F. A. Dinenno: Department of Health and Exercise Science, Colorado State University, 220 Moby-B Complex, Fort Collins, CO 80523-1582, USA. Email: fdinenno{at}cahs.colostate.edu
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
-adrenoceptor desensitization (Seals & Dinenno, 2004). Indeed, we recently demonstrated that post-junctional -adrenergic responsiveness to endogenous noradrenaline (NA) release is significantly reduced in the forearm vasculature of older healthy men, and that this is selective for 1-adrenoceptors (Dinenno et al. 2002). In contrast to these observations under resting conditions, it has been suggested that sympathetic vasoconstriction might be augmented in the skeletal muscle circulation of older humans during large-muscle dynamic exercise and contributes to the observed reductions in blood flow to exercising muscle with age (Proctor et al. 1998, 2003; Lawrenson et al. 2003; Poole et al. 2003).
In young healthy humans, it is well documented that sympathetic vasoconstrictor responses are blunted in the vascular beds of contracting skeletal muscle, a phenomenon referred to as ‘functional sympatholysis’ (Remensnyder et al. 1962; Hansen et al. 1996; Tschakovsky et al. 2002; Dinenno & Joyner, 2003). This unique ability of muscle contractions to limit the amount of vasoconstriction appears to be a local regulatory mechanism to ensure adequate blood flow and oxygen delivery to the contracting muscle, especially as sympathetic nervous system activity increases to maintain arterial blood pressure during exercise (Anderson & Faber, 1991; VanTeeffelen & Segal, 2003). With respect to ageing, recent data suggest that this ability of contracting muscle to blunt sympathetic vasoconstriction might be impaired in older men (Koch et al. 2003) and women (Fadel et al. 2004). However, due to the nature of the experimental designs in these previous studies, the effects of ageing on post-junctional 1- and 2-adrenoceptor responsiveness during exercise, and how this relates to functional sympatholysis, could not be determined.
With this information as a background, we tested the hypothesis that the normal ability of muscle contractions to blunt sympathetic -adrenergic vasoconstriction (functional sympatholysis) is impaired with age in healthy men. To do so, we measured forearm haemodynamics (Doppler ultrasound) during rhythmic handgrip exercise and intra-arterial infusion of adenosine (‘control’ vasodilator), and determined the vasoconstrictor responses to -adrenoceptor stimulation in discrete groups of young and older healthy men. Our findings indicate that human ageing is associated with an impaired modulation of -adrenergic vasoconstriction in the vascular beds of contracting forearm muscle.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
With Institutional Review Board approval and after obtaining written informed consent, a total of seven young and eight older healthy men participated in the present study. All were non-smokers, non-obese, normotensive, and not taking any medications. All subjects had normal levels of cholesterol and haemoglobin, were sedentary and free from overt cardiovascular disease. The older subjects were further evaluated for cardiopulmonary disease with a physical examination and resting and maximal exercise ECG measurements. Studies were performed after an overnight fast with the subjects in the supine position. All studies were performed according to the Declaration of Helsinki.
Brachial artery catheterization
In all subjects a 20-gauge, 5-cm catheter was placed in the brachial artery of the non-dominant arm under aseptic conditions after local anaesthesia (1% lignocaine (lidocaine)) for local administration of study drugs. The catheter was connected to a pressure transducer for mean arterial pressure (MAP) measurement and continuously flushed at 3 ml h–1 with heparinized saline (Dietz et al. 1994). After 30 min of rest (after catheterization but prior to any experimental trials), an arterial blood sample was taken for the determination of resting plasma NA concentrations via high performance liquid chromatography (Dinenno et al. 2002).
Forearm blood flow and vascular conductance
A 4-MHz pulsed Doppler probe (Model 500V, Multigon Industries, Mount Vernon, NY, USA) was used to measure brachial artery mean blood velocity (MBV) with the probe securely fixed to the skin over the brachial artery proximal to the catheter insertion site as previously described by us (Tschakovsky et al. 2002; Dinenno & Joyner, 2003, 2004). The probe insonation angle was 60 deg. A linear 7.0-MHz echo Doppler ultrasound probe (Acuson 128XP, Mountain View, CA, USA) was placed in a holder securely fixed to the skin immediately proximal to the velocity probe to measure brachial artery diameter. Forearm blood flow was calculated as:
|
|
Rhythmic handgrip exercise
In young healthy humans, functional sympatholysis is graded with the level of relative exercise intensity, such that exercise at a greater percentage of maximum voluntary contraction (MVC) causes progressively more sympatholysis (Hansen et al. 1996; Tschakovsky et al. 2002). Therefore, to account for any potential age-related differences in maximal handgrip strength, rhythmic forearm handgrip exercise was performed using a load that corresponded to 15% of the subjects' MVC. We chose this workload because (in young adults) it significantly blunts, but does not abolish, sympathetic vasoconstriction in contracting muscle (Tschakovsky et al. 2002; Dinenno & Joyner, 2003). MVC for each subject was determined as the average of at least three maximal squeezes of a handgrip dynamometer (Stoelting, Chicago, IL, USA) that were within 5% of each other. For the exercise trials, the weight was lifted 4–5 cm over a pulley at a duty cycle of 1 s contraction–2 s relaxation (20 contractions min–1) using audio and visual signals to ensure the correct timing (Dinenno & Joyner, 2003, 2004).
Sympathetic -adrenergic vasoconstrictor drugs
The following drugs were infused via the brachial artery catheter: tyramine was infused at 8 µg (dl forearm vol)–1 min–1 to evoke endogenous NA release from sympathetic nerve endings (Frewin & Whelan, 1968) and subsequent post-junctional 1- and 2-adrenergic vasoconstriction (Jie et al. 1987). It is important to note that tyramine does not have any direct vasoconstrictor effects (Frewin & Whelan, 1968), and the vascular responses to tyramine are abolished by non-selective -adrenergic blockade (Dinenno et al. 2002). Because it is very difficult to assess the endogenous NA release in response to tyramine under these experimental conditions, phenylephrine (a direct selective 1-agonist) was infused at 0.03125 µg (dl forearm vol)–1 min–1 and clonidine (a direct 2-agonist) was infused at 0.15 µg (dl forearm vol)–1 min–1 to determine post-junctional -adrenergic vasoconstrictor responsiveness (Dinenno et al. 2002; Dinenno & Joyner, 2003; Rosenmeier et al. 2003). Forearm volume was measured in all subjects via water displacement. All vasoconstrictor drug infusions were adjusted for the hyperaemic conditions as described below.
To elevate resting forearm blood flow to similar levels observed during exercise, we infused adenosine (6.25 µg (dl forearm vol)–1 min–1) via the brachial artery catheter (‘passive’ vasodilatation). We have previously demonstrated that exercise blunts the vasoconstrictor responses to tyramine, phenylephrine and clonidine, whereas these vasoconstrictor responses are maintained when blood flow is passively elevated with adenosine (‘control’ vasodilator condition) (Tschakovsky et al. 2002; Dinenno & Joyner, 2003; Rosenmeier et al. 2003). Therefore, sympathetic -adrenergic vasoconstrictor responses were compared during ‘high-flow’ states in the presence (exercise) and absence (adenosine infusion) of muscle contractions. It is important to note that all vasoconstrictor infusions were adjusted on the basis of steady-state forearm blood flow and forearm volume. These adjustments were made in an effort to normalize the concentrations of each constrictor drug in the blood perfusing the forearm across conditions where blood flow might differ within and between age groups. The concentrations of study drugs were calculated to make sure the absolute infusion rate did not impact on forearm haemodynamics (< 3 ml min–1 in every trial).
General experimental protocol
Figure 1 is an example of a time-line for the specific trials. The subjects performed a bout of forearm exercise or received intra-arterial adenosine in a randomized and counterbalanced manner; the total time for each trial was 9 min. After 2 min of baseline measurements, exercise or adenosine infusion was initiated and steady-state FBF was reached within 3 min. Between 3 and 4 min of hyperaemia (min 5 and 6 of Fig. 1) the dose of the vasoconstricting agent was calculated on the basis of forearm volume and blood flow. The vasoconstrictor infusion began at the 6-min mark and lasted for 3 min. Subjects rested for 15 min between trials.
|
Data was collected and stored on computer at 250 Hz and analysed off-line with signal-processing software (WinDaq, DATAQ Instruments, Akron, OH, USA). MAP was determined from the arterial pressure waveform. Baseline FBF and MAP represent an average of the last minute of the resting time period, the steady-state hyperaemic values represent an average of min 3–4 (min 5–6 of Fig. 1; pre-vasoconstrictor) during adenosine infusion or exercise, and the effects of the -agonists represent an average of the final 30-s of drug infusion (post-vasoconstrictor).
The percentage reduction in FVC during vasoconstrictor administration was calculated as:
|
|
We used percentage reduction in FVC as our standard index to compare vasoconstrictor responses to the -agonists across conditions, as this has emerged as the most appropriate way to compare vasoconstrictor responsiveness under conditions where there might be marked differences in baseline blood flow (Thomas et al. 1994; Buckwalter & Clifford, 2001; Tschakovsky et al. 2002). As an alternative way of expressing the data, for both age groups we calculated the ‘magnitude of sympatholysis’ as the difference between the vasoconstrictor responses during adenosine and those during exercise. In other words, this index of functional sympatholysis reflects the ability of muscle contractions to blunt the vasoconstrictor response observed under resting control vasodilator conditions.
Statistics
All values are reported as means ± S.E.M. Age-group comparisons for subject characteristics, haemodynamic variables during adenosine infusion and exercise, and forearm vasoconstrictor responses were performed using unpaired t tests. Within group comparisons of the haemodynamic values at specific time points between the exercise and adenosine conditions were made with paired t tests, as were the within-group comparisons in the vasoconstrictor responses during adenosine infusion versus exercise. Significance was set at P < 0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
100% greater in the older men (P < 0.005).
|
Forearm haemodynamics and MAP are presented in Tables 2–
4. In general, adenosine increased FBF and FVC significantly in young and older men such that the steady-state levels of FBF and FVC were similar in both groups (P
= 0.2–0.9). FBF and FVC during exercise also were not significantly different in the two groups (P
= 0.2–0.6). Although the steady-state forearm haemodynamics during adenosine infusion were consistently lower compared with exercise in both groups, these differences never reached statistical significance (P
= 0.2–0.9).
|
|
|
The vasoconstrictor responses to tyramine during passive vasodilatation with adenosine were significantly lower in older compared with young men (change in FVC (
FVC), –36 ± 7%
versus
–56 ± 6%; P < 0.05; Fig. 2A). In young men, the vasoconstrictor responses to tyramine during exercise were significantly blunted compared with the responses during adenosine infusion (FVC, –25 ± 1%
versus
–56 ± 6%; P < 0.005), indicating functional sympatholysis. In contrast, the vasoconstrictor responses during exercise in older men were not different during exercise compared with adenosine infusion (FVC, –30 ± 2%
versus
–36 ± 7%; P
= 0.4). The magnitude of sympatholysis (i.e. amount of blunting by muscle contractions) was significantly less in the older compared with young men (–6 ± 7%
versus
–31 ± 6%; P < 0.01; Fig. 2B).
|
1-receptor stimulation)
The vasoconstrictor responses to phenylephrine during passive vasodilatation with adenosine were significantly lower in older compared with young men (FVC, –19 ± 3%
versus
–39 ± 4%; P < 0.005; Fig. 3A). In young men, the vasoconstrictor responses to phenylephrine during exercise were significantly blunted compared with the responses during adenosine infusion (FVC, –11 ± 4%
versus
–39 ± 4%; P < 0.001). In contrast, the vasoconstrictor responses during exercise in older men were not blunted during exercise compared with adenosine infusion (FVC, –16 ± 2%
versus
–19 ± 3%; P
= 0.3). The magnitude of sympatholysis was significantly less in the older men compared with the young men (–3 ± 3%
versus
–28 ± 4%; P < 0.01; Fig. 3B).
|
2-receptor stimulation)
The vasoconstrictor responses to clonidine during passive vasodilatation with adenosine were similar in older compared with young men (FVC, –37 ± 6%
versus
–38 ± 5%; P > 0.9; Fig. 4A). In young men, the vasoconstrictor responses to clonidine during exercise were significantly blunted compared with the responses during adenosine infusion (FVC, –12 ± 4%
versus
–38 ± 5%; P < 0.001). The vasoconstrictor responses during exercise in older men were also blunted during exercise compared with adenosine infusion (FVC, –22 ± 3%
versus
–37 ± 6%; P < 0.005). Because the vasoconstrictor responses during adenosine infusion were similar between the age groups, we could directly compare the vasoconstrictor responses to clonidine during exercise. When this comparison was made, the older men demonstrated greater vasoconstrictor responses during exercise compared with the young men (–22 ± 3%
versus
–12 ± 4%; P < 0.05). Additionally, the magnitude of sympatholysis (i.e. amount of blunting) was less in the older men compared with the young men (–15 ± 4%
versus
–26 ± 3%; P < 0.05; Fig. 4B).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
-adrenergic agonists was significantly impaired in the older men. Taken together, the findings from this investigation provide the first experimental evidence of impaired modulation of post-junctional -adrenoceptor control of muscle vascular tone during exercise with age in humans.
Ageing and -adrenergic responsiveness during passive vasodilatation
Because there are some concerns comparing muscle vasoconstrictor responses under resting (low blood flow) conditions with those during contractions (high blood flow), we locally infused adenosine in an attempt to increase forearm blood flow to levels similar to those observed during exercise (Dinenno & Joyner, 2003, 2004). Under these conditions of passive vasodilatation with adenosine, we found that the vasoconstrictor responses to tyramine and phenylephrine were significantly reduced in the older compared with young men (Figs 2A and 3A), whereas the responses to clonidine were similar (Fig. 4A). These data are similar to what we found in a previous study under normal resting conditions (Dinenno et al. 2002). Therefore, these data indicate that passive vasodilatation via adenosine does not impact on the age-related decline in -adrenoceptor responsiveness in resting muscle. Taken together, these data indicate that ageing is associated with reduced vasoconstrictor responsiveness to endogenous NA release in resting muscle resistance vessels, and that this appears selective for post-junctional 1-adrenoceptors.
Ageing and -adrenergic responsiveness during rhythmic handgrip exercise
In the young men, the vasoconstrictor responses to tyramine and direct 1- (phenylephrine) and 2- (clonidine) adrenoceptor agonists were significantly blunted during exercise compared with the responses during adenosine infusion. This is consistent with our previous observations and indicates functional sympatholysis in the vascular beds of contracting muscle (Tschakovsky et al. 2002; Dinenno & Joyner, 2003, 2004). In contrast, in the older men, the vasoconstrictor responses to tyramine (Fig. 2A) and phenylephrine (Fig. 3A) during exercise were similar to those during adenosine infusion indicating impaired functional sympatholysis (i.e. intact vasoconstriction). Although the older men did demonstrate an ability to blunt the responses to clonidine during exercise, the vasoconstrictor responses were greater than in young men (Fig. 4A) and the magnitude of functional sympatholysis was impaired compared with the young men (Fig. 4B). Collectively, these data indicate that ageing is associated with an impaired modulation of sympathetic -adrenergic vasoconstriction in contracting muscle of humans.
The findings from the present study extend those from two recent studies on this topic and provide the first direct evidence of impaired modulation of post-junctional -adrenoceptor control of vascular tone during exercise in ageing humans. Koch et al. (2003) demonstrated a greater active muscle vasoconstrictor response in older men during cycling, using a cold pressor test to activate the sympathetic nervous system (similar to our findings with clonidine). Unfortunately, vasoconstrictor responses were not measured in resting muscle, limiting the ability to quantify the magnitude of functional sympatholysis in contracting muscle. Fadel et al. (2004) recently showed that the vasoconstrictor responses during sympatho-excitation (via lower body negative pressure) in contracting forearm muscles were significantly blunted in young women, but not in older oestrogen-deficient postmenopausal women. However, the lack of direct neural recordings and the measurement of sympathetic nerve activity in response to this stimulus preclude a definitive interpretation of the data as they pertain to ageing. Nevertheless, the collective data from all of these studies support the hypothesis that the ability to blunt sympathetic vasoconstriction in the vascular beds of contracting muscle is impaired with age.
Possible mechanisms
The mechanisms involved in functional sympatholysis in young healthy humans have been difficult to elucidate and it appears that various substances released from the active muscle or vascular endothelium can, under certain conditions and/or experimental models, blunt sympathetic vasoconstriction. Nitric oxide (NO) (Thomas & Victor, 1998; Chavoshan et al. 2002), prostaglandins (Faber et al. 1982), red blood cell-derived ATP (Rosenmeier et al. 2004) and activation of ATP-dependent K+ (KATP) channels (Thomas et al. 1997; Keller et al. 2004) have all been implicated in functional sympatholysis. As such, it is likely that there are redundant pathways involved in this phenomenon to ensure adequate blood flow and oxygen delivery to contracting muscle under conditions of sympathetic activation (VanTeeffelen & Segal, 2003).
Recent data from our laboratory indicate that combined inhibition of NO and vasodilator prostaglandins (PGs) augments sympathetic vasoconstrictor responses in contracting forearm muscle of young adults (Dinenno & Joyner, 2004). It is interesting that ageing is associated with elevations in oxidative stress that reduces endothelium-derived NO bioavailability (Taddei et al. 2001) and also promotes the production of cyclooxygenase-derived vasoconstrictor prostanoids (Taddei et al. 1997). Therefore, we speculate that the age-related impairment in endothelial function, and specifically NO and vasodilator PG bioavailability, could lead to an impaired ability to blunt sympathetic vasoconstriction in contracting muscle of older adults. This could also be the case for heart failure patients, a patient population that demonstrates exercise intolerance, oxidative stress-induced endothelial dysfunction, and exaggerated sympathetic nervous system responses during exercise (Silber et al. 1998; Thomas et al. 2001). Obviously, future studies will be necessary to determine the mechanism(s) underlying this age-related impairment in the modulation of sympathetic vasoconstriction in contracting muscles.
Experimental considerations
In this study, we did not measure changes in deep venous NA concentrations in response to tyramine (which evokes endogenous NA release) or to clonidine (which can inhibit NA release via stimulation of pre-junctional 2-adrenoceptors) as in our previous study (Dinenno et al. 2002) due to technical challenges associated with the experimental set-up. However, we used doses of each drug that most probably resulted in similar changes in NA release in both groups (Dinenno et al. 2002), and evidence from experimental dogs indicate that the effects of clonidine during exercise are primarily at the level of post-junctional 2-adrenoceptors (Buckwalter et al. 2001). Additionally, the age-group responses to the -adrenergic vasoconstrictors (tyramine, phenylephrine and clonidine) during passive vasodilatation with adenosine were similar to what we found in our previous study under normal resting conditions (Dinenno et al. 2002). Therefore, we do not feel this limits the interpretation of our data. Further, the extent to which functional sympatholysis is due to pre-junctional inhibition of NA release in young adults, or the extent to which the impaired modulation of sympathetic vasoconstriction in older adults is due to impaired inhibition of NA release, is currently unknown and requires further study. Nevertheless, the data obtained during infusions of the direct -agonists (phenylephrine and clonidine) clearly indicate a role for post-junctional -adrenoceptors in this phenomenon in both young and older humans.
A final consideration relates to the age-related reduction in post-junctional -adrenergic responsiveness under resting conditions and how this might impact on the interpretation of our data. As discussed previously, our recent study under normal resting conditions demonstrated a significantly reduced forearm vasoconstrictor response to tyramine and phenylephrine (but not clonidine) in older men (Dinenno et al. 2002). However, in the present study we were unsure how local administration of adenosine would impact on the age-associated changes in vasoconstrictor responsiveness to the -adrenergic agonists, and therefore did not attempt to match the young and older men's control vasoconstrictor responses for comparison with the responses during exercise. Because the age-related impairment in the magnitude of functional sympatholysis was substantially greater for tyramine and phenylephrine (reduced control vasoconstrictor responses) compared with clonidine (normal control vasoconstrictor responses), one could question whether this truly reflects age-related differences in the responses to endogenous NA release and selective 1-adrenoceptor stimulation as compared with 2-adrenoceptor stimulation during exercise. However, in young adults, sympatho-excitation evoked via lower body negative pressure causes only 20% vasoconstriction under resting conditions (similar to tyramine and phenylephrine in the older men of this study), but is nearly abolished in exercising muscle at similar intensities used in our study (Hansen et al. 1996; Chavoshan et al. 2002; F. Dinenno, unpublished observations). Therefore, although the control vasoconstrictor responses to tyramine and phenylephrine were lower in the older men, we do not believe that this contributed to their inability to blunt these responses in active muscle. Future studies will be needed to fully address this issue.
Perspectives
The regulation of active muscle blood flow during large muscle dynamic exercise involves the complex interactions between the mechanical effects of muscle contraction (i.e. muscle pump), metabolic and flow-induced vasodilator substances, and the sympathetic nervous system (Saltin et al. 1998). Because the ability of the skeletal muscle vasculature to dilate can exceed the pumping capacity of the heart (Anderson & Saltin, 1985), sympathetic vasoconstriction must occur in active muscle to maintain arterial blood pressure (Marshall et al. 1961). With respect to -adrenoceptor control of muscle blood flow, there is evidence in rats to suggest that 2-adrenoceptors are predominantly located on small resistance vessels and therefore are particularly susceptible to by-products of muscle contraction and facilitate the distribution of blood flow and oxygen delivery to the active muscle (Anderson & Faber, 1991). In contrast, 1-receptors are thought to be located predominantly on larger resistance vessels (Anderson & Faber, 1991) and regulate whole-muscle blood flow and vascular resistance, thereby contributing to appropriate blood pressure regulation (Anderson & Faber, 1991; VanTeeffelen & Segal, 2003). This scheme regarding the integrative control of active muscle blood flow, vascular tone and arterial blood pressure will now be discussed in the context of ageing.
During dynamic exercise, sympathetic vasoconstrictor activity increases progressively with increased recruitment of muscle mass and with increased exercise intensity (Seals & Victor, 1991). As sympathetic activity directed to resistance vessels in active muscle increases during exercise, the regulation of vascular resistance moves upstream to larger skeletal muscle resistance vessels (Ohyanagi et al. 1991). In ageing humans, muscle blood flow during submaximal large-muscle dynamic exercise is reduced despite augmented blood pressure (perfusion pressure) responses (Poole et al. 2003; Proctor et al. 2003). Thus, the impaired muscle blood flow response with age is due to a reduced skeletal muscle vascular conductance (i.e. augmented vasoconstrictor or reduced vasodilator tone). The findings of the present study indicate that the ability of muscle contractions to blunt 1-mediated vasoconstriction is severely impaired with age (Fig. 3). Thus, this impaired modulation of -adrenoceptor responsiveness (and specifically 1-receptor control) could potentially lead to impaired muscle blood flow responses via reductions in muscle vascular conductance, and could also explain the exaggerated blood pressure responses during exercise in older adults.
An additional consideration relates to the age-related reduction in maximal aerobic exercise capacity. Recent evidence indicates that maximal cardiac output can be maintained with age in healthy humans, strongly implicating a causative role for impairments in ‘peripheral’ factors (e.g. muscle blood flow control and/or distribution, oxygen extraction) in the age-related decline in exercise capacity (McGuire et al. 2001). Because sympathetic activity appears to be exaggerated in older adults during high-intensity exercise (Taylor et al. 1992; Proctor et al. 1998), an impaired ability to blunt sympathetic vasoconstriction in active muscle could potentially contribute to reduced blood flow and oxygen delivery to contracting skeletal muscle, thereby limiting oxygen uptake and exercise capacity.
Conclusions
The results from the present investigation demonstrate that the normal ability of muscle contractions to blunt sympathetic -adrenergic vasoconstriction in the vascular beds of active muscle is significantly impaired in ageing men. This might help explain the augmented vasoconstrictor tone and reduced muscle blood flow, as well as the exaggerated blood pressure responses, observed in older adults during large-muscle dynamic exercise.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Anderson
P
&
Saltin
B (1985). Maximal perfusion of skeletal muscle in man. J Physiol
366, 233–249.
Buckwalter JB & Clifford PS (2001). The paradox of sympathetic vasoconstriction in exercising skeletal muscle. Exerc Sports Sci Rev 29, 159–163.[CrossRef]
Buckwalter
JB, Naik
JS, Valic
Z
&
Clifford
PS (2001). Exercise attenuates alpha-adrenergic-receptor responsiveness in skeletal muscle vasculature. J Appl Physiol
90, 172–178.
Chavoshan
B, Sander
M, Sybert
TE, Hansen
J, Victor
RG
&
Thomas
GD (2002). Nitric oxide-dependent modulation of sympathetic neural control of oxygenation in exercising human skeletal muscle. J Physiol
540, 377–386.
Davy
KP, Seals
DR
&
Tanaka
H (1998). Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension
32, 298–304.
Dietz NM, Rivera JM, Eggener ES, Fix RJ, Warner DO & Joyner MJ (1994). Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol 480, 361–368.[Medline]
Dinenno
FA, Dietz
NM
&
Joyner
MJ (2002). Aging and forearm postjunctional -adrenergic vasoconstriction in healthy men. Circulation
106, 1349–1354.
Dinenno
FA
&
Joyner
MJ (2003). Blunted sympathetic vasoconstriction in contracting skeletal muscle of healthy humans: is nitric oxide obligatory?
J Physiol
553, 281–292.
Dinenno
FA
&
Joyner
MJ (2004). Combined NO and PG inhibition augments -adrenergic vasoconstriction in contracting human skeletal muscle. Am J Physiol Heart Circ Physiol
287, H2576–H2584.
Faber JE, Harris PD & Joshua IG (1982). Microvascular response to blockade of prostaglandin synthesis in rat skeletal muscle. Am J Physiol 243, H51–H60.[Medline]
Fadel
PJ, Wang
Z, Watanabe
H, Arbique
D, Vongpatanasin
W
&
Thomas
GD (2004). Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy. J Physiol
561, 893–901.
Frewin DB & Whelan RF (1968). The mechanism of action of tyramine on the blood vessels of the forearm in man. Br J Pharmacol 22, 105–116.
Hansen J, Thomas GD, Harris SA, Parsons WJ & Victor RG (1996). Differential sympathetic neural control of oxygenation in resting and exercising human skeletal muscle. J Clin Invest 98, 584–596.[Medline]
Hogikyan RV & Supiano MA (1994). Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol 266, E717–E724.[Medline]
Jie K, van Brummelen P, Vermey P, Timmermans P & van Zwieten PA (1987). Postsynaptic alpha1 and alpha2-adrenoceptors in human blood vessels: interactions with exogenous and endogenous catecholamines. Eur J Clin Invest 17, 174–181.[Medline]
Keller
DM, Ogoh
S, Greene
S, Olivencia-Yurvati
A
&
Raven
PB (2004). Inhibition of KATP channel activity augments baroreflex-mediated vasoconstriction in exercising human skeletal muscle. J Physiol
561, 273–282.
Koch
DW, Leuenberger
U
&
Proctor
DN (2003). Augmented leg vasoconstriction in dynamically exercising older men during acute sympathetic stimulation. J Physiol
551, 337–344.
Lawrenson
L, Poole
JG, Kim
J, Brown
C, Patel
P
&
Richardson
RS (2003). Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol
285, H1023–H1031.
McGuire
DK, Levine
BD, Williamson
JW, Snell
PG, Blomqvist
CG, Saltin
B
&
Mitchell
JH (2001). A 30-year follow-up of the Dallas bed rest and training study: effect of age on the cardiovascular response to exercise. Circulation
104, 1350–1357.
Marshall
RJ, Schirger
A
&
Shepherd
JT (1961). Blood pressure during supine exercise in idiopathic orthostatic hypotension. Circulation
24, 76–81.
Ng
AV, Callister
R, Johnson
DG
&
Seals
DR (1993). Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension
21, 498–503.
Ohyanagi
M, Faber
JE
&
Nishigaki
K (1991). Differential activation of alpha 1- and alpha 2-adrenoceptors on microvascular smooth muscle during sympathetic nerve stimulation. Circ Res
68, 232–244.
Poole
JG, Lawrenson
L, Kim
J, Brown
C
&
Richardson
RS (2003). Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol
284, H1251–H1259.
Proctor
DN, Koch
DW, Newcomer
SC, Le
KU
&
Leuenberger
UA (2003). Impaired leg vasodilation during dynamic exercise in healthy older women. J Appl Physiol
95, 1963–1970.
Proctor
DN, Shen
PH, Dietz
NM, Eickhoff
TJ, Lawler
LA, Ebersold
EJ, Loeffler
DL
&
Joyner
MJ (1998). Reduced leg blood flow during dynamic exercise in older endurance trained men. J Appl Physiol
85, 68–75.
Remensnyder
JP, Mitchell
JH
&
Sarnoff
SJ (1962). Functional sympatholysis during muscular activity. Circ Res
11, 370–380.
Rosenmeier
JB, Dinenno
FA, Fritzlar
SJ
&
Joyner
MJ (2003). 1- and 2-adrenergic vasoconstriction is blunted in contracting human muscle. J Physiol
547, 971–976.
Rosenmeier
JB, Hansen
J
&
Gonzalez-Alonso
J (2004). Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle. J Physiol
558, 351–365.
Saltin B, Radegran G, Koskolou MD & Roach RC (1998). Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 162, 421–436.[CrossRef][Medline]
Seals
DR
&
Dinenno
FA (2004). Collateral damage: cardiovascular consequences of chronic sympathetic activation with human aging. Am J Physiol Heart Circ Physiol
287, H1895–H1905.
Seals DR & Victor RG (1991). Regulation of muscle sympathetic nerve activity during exercise in humans. Exerc Sports Sci Rev 19, 313–349.
Silber
DH, Sutliff
G, Yang
QX, Smith
MB, Sinoway
LI
&
Leuenberger
UA (1998). Altered mechanisms of sympathetic activation during rhythmic forearm exercise in heart failure. J Appl Physiol
84, 1551–1559.
Sundlof
G
&
Wallin
BG (1978). Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol
274, 621–637.
Taddei
S, Virdis
A, Ghiadoni
L, Magagna
A
&
Salvetti
A (1997). Cyclooxygenase inhibition restrores nitric oxide activity in essential hypertension. Hypertension
29, 274–279.
Taddei
S, Virdis
A, Ghiadoni
L, Salvetti
G, Bernini
G, Magagna
A
&
Salvetti
A (2001). Age-related reduction of NO availability and oxidative stress in humans. Hypertension
38, 274–279.
Taylor
JA, Hand
GA, Johnson
DG
&
Seals
DR (1992). Augmented forearm vasoconstriction during dynamic exercise in healthy older men. Circulation
86, 1789–1799.
Thomas GD, Hansen J & Victor RG (1994). Inhibition of alpha-2 adrenergic vasoconstriction during contraction of glycolytic, not oxidative, rat hindlimb muscle. Am J Physiol 266, H920–H929.[Medline]
Thomas GD, Hansen J & Victor RG (1997). ATP-sensitive potassium channels mediate contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Clin Invest 99, 2602–2609.[Medline]
Thomas
GD
&
Victor
RG (1998). Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J Physiol
506, 817–826.
Thomas
GD, Zhang
W
&
Victor
RG (2001). Impaired modulation of sympathetic vasoconstriction in contracting skeletal muscle of rats with chronic myocardial infarctions: role of oxidative stress. Circ Res
88, 816–823.
Tschakovsky
ME, Sujirattanawimol
K, Ruble
SB, Valic
Z
&
Joyner
MJ (2002). Is sympathetic neural vasoconstriction blunted in the vascular bed of exercising human muscle?
J Physiol
541, 623–635.
VanTeeffelen
JW
&
Segal
SS (2003). Interaction between sympathetic nerve activation and muscle fibre contraction in resistance vessels of hamster retractor muscle. J Physiol
550, 563–574.
|
Acknowledgements |
|---|
This article has been cited by other articles:
|
|
 |
|
  D. W. Wray, S. K. Nishiyama, R. A. Harris, and R. S. Richardson Angiotensin II in the Elderly: Impact of Angiotensin II Type 1 Receptor Sensitivity on Peripheral Hemodynamics Hypertension, June 1, 2008; 51(6): 1611 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Carlson, B. S. Kirby, W. F. Voyles, and F. A. Dinenno Evidence for impaired skeletal muscle contraction-induced rapid vasodilation in aging humans Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1963 - H1970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Edemir, S. Reuter, R. Borgulya, R. Schroter, U. Neugebauer, G. Gabriels, and E. Schlatter Acute Rejection Modulates Gene Expression in the Collecting Duct J. Am. Soc. Nephrol., March 1, 2008; 19(3): 538 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Smith, W. F. Voyles, B. S. Kirby, R. R. Markwald, and F. A. Dinenno Ageing and leg postjunctional {alpha}-adrenergic vasoconstrictor responsiveness in healthy men J. Physiol., July 1, 2007; 582(1): 63 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Donato, L. A. Lesniewski, and M. D. Delp Ageing and exercise training alter adrenergic vasomotor responses of rat skeletal muscle arterioles J. Physiol., February 15, 2007; 579(1): 115 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. Schrage, J. H. Eisenach, and M. J. Joyner Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans J. Physiol., February 15, 2007; 579(1): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Wray, A. J. Donato, S. K. Nishiyama, and R. S. Richardson Acute sympathetic vasoconstriction at rest and during dynamic exercise in cyclists and sedentary humans J Appl Physiol, February 1, 2007; 102(2): 704 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhao, S. A. Swanson, J. Ye, X. Li, J. M. Shelton, W. Zhang, and G. D. Thomas Reactive Oxygen Species Impair Sympathetic Vasoregulation in Skeletal Muscle in Angiotensin II-Dependent Hypertension Hypertension, October 1, 2006; 48(4): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Joyner Too Much Is Not Enough: Hypertension and Sympathetic Vasoconstriction in Contracting Muscles Hypertension, October 1, 2006; 48(4): 560 - 561. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||
P < 0.05 versus adenosine within same age group.
